Several possible studies
Story checked
New study reveals how Candida auris evades antifungal drugs (opens in a new tab)
news-medical.net · 2026-10-15
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
New study reveals how Candida auris evades antifungal drugs
news-medical.net · 2026-10-15
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Source layer
The paper behind the story
The source record for this check.
The research anchor for the report.
- Points somewhere elsementioned without context
10.1038/s41467-026-76954-x
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 7Not checkedA new study revealed an unexpected mechanism through which Candida auris is resisting antifungal drug treatment.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 7Not checkedResearchers from the University of Exeter and City St George's, University of London found that the fungus creates multiple versions of its entire genome, including mutations in CRZ1, a gene involved in cell wall integrity.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 7Not checkedThe study is published in Nature Communications and was funded by the Medical Research Council, with support from the NIHR Biomedical Research Centre: Exeter.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 7Not checkedStudy authors say the findings unlock a brand new mechanism that allows Candida auris to adapt to antifungal treatment and survive, which could lead to new ways to tackle the fungus.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 7Not checkedThe researchers say that surviving cells had made multiple copies of the entire genome, and that two populations existed: some growing slowly and others more rapidly.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 7Not checkedFurther tests confirmed the rapid growth of CRZ1 mutants, and that their cell walls appeared to be unaffected by antifungal drugs.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 7 of 7Not checkedResearchers are now looking at antifungal combinations as a possible next step.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Crossref, Europe PMC · 15 candidate papers
Segmental duplications and supernumerary chromosomes drive antifungal drug resistance in Candida auris.
Nature Communications · 2026 · PubMed
Deciphering Candida auris Paradoxical Growth Effect (Eagle Effect) in Response to Echinocandins
Methods in Molecular Biology (Clifton, N.J.) · 2022 · PubMed, Crossref
In Vitro Activity and In Vivo Efficacy in a Murine Model of Rezafungin, Anidulafungin, Caspofungin, and Micafungin Against the Fifth Clade of Candida (Candidozyma) auris.
2026 · Europe PMC
Caspofungin paradoxical growth in Candida albicans requires stress pathway activation and promotes unstable echinocandin resistance mediated by aneuploidy
Frontiers in Cellular and Infection Microbiology · 2025 · Crossref
Phosphoproteomics of WHO-Priority Fungal Pathogens: Conserved Signaling Architecture, Pathogen-Specific Outputs, and Therapeutic Vulnerabilities.
2026 · Europe PMC
And 10 more candidates considered.